Oct 13, 2025 08:00AM

Oct 13, 2025 08:00AM

May 22, 2025 08:20AM

May 22, 2025 08:05AM

Apr 3, 2025 08:26AM

Apr 3, 2025 08:26AM

Dec 10, 2024 08:06AM Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through

Dec 10, 2024 08:05AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All